What does CUSIP 00289Y107 represent in this 13F holders report?

CUSIP 00289Y107 is the security identifier for ABEO - ABEONA THERAPEUTICS INC - COM used to aggregate holder disclosures.

How many institutions held ABEO - ABEONA THERAPEUTICS INC - COM in Q1 2022?

46 institutional investors reported ABEO - ABEONA THERAPEUTICS INC - COM for Q1 2022. Use the holders table for investor-level position and value details.

ABEONA THERAPEUTICS INC - COM (ABEO)

CUSIP: 00289Y107

Q1 2022 13F Holders as of 31 Mar 2022

Security type / class: Equity / COM
Total 13F shares: 32,609,380
Total 13F value: $10,277,038
Share change: -6,477,213
SEC-reported price per share: $0.31
Number of holders: 46
Value change: -$2,038,846
Number of buys: 13
Number of sells: 19

Security key

00289Y107

Report period

Q1 2022

Institutions

Top holders

ABEO full security history Ownership snapshot Full 13F holder table ABEONA THERAPEUTICS INC. SEC filings ABEONA THERAPEUTICS INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ABEO - ABEONA THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Steven H. Rouhandeh

Disclosed value leader

Steven H. Rouhandeh

Comparable rows

0/15

Latest evidence

31 Dec 2021

3/4/5 13F Highest disclosed value: $2,726,645 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Steven H. Rouhandeh has the largest disclosed position value at $2.73M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Steven H. Rouhandeh's linked filing trail.

Disclosed position value Top 5

Steven H. Rouhandeh $2.73M

ADAGE CAPITAL PARTNERS GP, L.L.C. $2.7M

Edward Carr $2.04M

VANGUARD GROUP INC $1.23M

MORGAN STANLEY $1.14M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Steven H. Rouhandeh	3/4/5 Director, 10%+ Owner 3/4/5	— mixed-class rows	$2,726,645 582,674 shares mixed-class rows	—	25 May 2021
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F Company 13F	— denominator unverified	$2,698,000 8,007,272 shares	—	31 Dec 2021
Edward Carr	3/4/5 Chief Financial Officer 3/4/5	— denominator unverified	$2,044,864 400,169 shares	—	08 Oct 2021
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$1,234,000 3,661,496 shares	—	31 Dec 2021
MORGAN STANLEY	13F Company 13F	— denominator unverified	$1,136,000 3,370,334 shares	—	31 Dec 2021
Point72 Asset Management, L.P.	13F Company 13F	— denominator unverified	$1,078,000 3,200,000 shares	—	31 Dec 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

32,609,380

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q1 2022 value	Q1 2022 value	Value change	Value Chg %